Weizmann Institute Of Science

Rehovot, Center District

UEI
NPJ8YBLFTKX6
CAGE
2846A
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Private University or College
  • Non-Profit Organization
  • Educational Institution
Entity structure
Corporate Entity (Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
Hertsel St 234, Rehovot, 7610001, Israel
Website
weizmann.ac.il
Founded
1934
Employees
1K-5K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Weizmann Institute Of Science's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Globals - global omic biomarker research for ALS Grant · HT94252510909 Defense Health Agency $939,325
Dense atomic arrays in optical tweezers for efficient quantum nodes Grant · FA86552517058 Air Forces Europe and Africa $360,000
Exploring decoherence with long-lived superconducting cavity qubits. Grant · W911NF2510196 ACC Aberdeen Proving Ground $225,000
Autonomous cell-free ribosome biogenesis reconstituted on a photonic chip Grant · W911NF2510093 ACC Aberdeen Proving Ground $434,240
New start grant Grant · W911NF2410392 ACC Aberdeen Proving Ground $450,000

About Weizmann Institute Of Science

Weizmann Institute of Science is a prestigious Israeli research institution located in Rehovot that operates as a tax-exempt corporate entity and private university. The organization is registered with SAM.gov and maintains active federal relationships as both a prime recipient and subrecipient of U.S. federal awards. Through its engagement with federal contract and grant programs, Weizmann Institute provides advanced scientific research services spanning quantum computing, biomedical research, materials science, and biotechnology—domains critical to both civilian and national defense applications.

Through federal contract awards, Weizmann Institute has demonstrated its capacity to provide specialized laboratory and analytical services. Most notably, the National Cancer Institute awarded the Institute a purchase order contract valued at $12,000 on February 1, 2023, for support in assaying DNA samples from the Benzene Biomarker Study, with completion targeted for January 31, 2024. This contract exemplifies the Institute's role in providing diagnostic and analytical support for epidemiological and biomarker research. While Weizmann maintains status as a prime contract awardee, the contract vehicle history reflects a limited direct contracting engagement, with the majority of federal funding flowing through grant mechanisms rather than traditional procurement contracts.

Weizmann Institute's primary federal engagement occurs through research grant awards across multiple federal agencies and programs. The institute has received substantial funding from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420), including a $939,325 project grant awarded November 1, 2025, supporting global omic biomarker research for amyotrophic lateral sclerosis (ALS) through October 31, 2028, as well as a $896,775 award from the Army Medical Command supporting breast cancer metastasis research. Additional prime grants include a $180,000 Air Force Research Sciences Program award for quantum computing research on dense atomic arrays in optical tweezers, multiple Army Research Office basic science grants totaling over $315,000 for quantum information processing research, and grants from the Office of Naval Research addressing plasma physics, synthetic biology, and materials science. The Institute also received significant support from the National Cancer Institute, including a $180,000+ cooperative agreement examining lung cancer risk prediction through DNA repair assays. Beyond prime awards, Weizmann serves as a subrecipient on numerous federal grants from leading U.S. institutions including Stanford University, University of California systems, University of Michigan, Columbia University, NYU, Brigham and Women's Hospital, and others, contributing computational biology expertise, spectroscopy diagnostics, and specialized research capabilities to collaborative multi-institutional projects spanning immunology, neurodevelopment, cancer biology, and advanced technology development.

Quick answers

What is Weizmann Institute Of Science's UEI?

Weizmann Institute Of Science's Unique Entity ID (UEI) in SAM.gov is NPJ8YBLFTKX6.

What is Weizmann Institute Of Science's CAGE code?

Weizmann Institute Of Science's CAGE code is 2846A.

What is Weizmann Institute Of Science's primary NAICS code?

Weizmann Institute Of Science's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Weizmann Institute Of Science located?

Weizmann Institute Of Science's physical address in SAM.gov is Hertsel St 234, Rehovot, 7610001, Israel.

Is Weizmann Institute Of Science registered in SAM.gov?

Yes. Weizmann Institute Of Science's SAM.gov registration is active through May 17, 2027.

What is Weizmann Institute Of Science's most recent federal award?

Weizmann Institute Of Science's most recent federal grant award is Globals - global omic biomarker research for ALS (HT94252510909), from Defense Health Agency, on November 1, 2025.

On GovTribe

See Weizmann Institute Of Science's full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors